Current Liabilities
Vertex Pharmaceuticals·Balance Sheet Statement·5 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total current liabilities | $3.5B | $4B | $3.6B | $3.8B | $4.1B | $4.5B | $3.9B | $3.9B |
| Other Commercial Liabilities | $2.9B | $3.2B | $2.8B | $3B | $3.3B | $3.6B | $3B | $3B |
| Accrued Liabilities, Current | $2.9B | $3.2B | $2.8B | $3B | $3.3B | $3.6B | $3B | $3B |
| Accounts payable | $327.9M | $395.8M | $413M | $445M | $442.3M | $420.3M | $461.7M | $489.3M |
| Other accrued liabilities | $279.3M | $357.6M | $363M | $386.4M | $425.4M | $441.5M | $428.3M | $407.1M |